RESULTS OF 96-WEEK FOLLOW-UP AFTER DISCONTINUATION OF NUCLEOS(T)IDE ANALOGUE THERAPY IN CHRONIC HEPATITIS B GENOTYPE D REGION (NUCSTOP STUDY)

被引：0
|
作者：
Kiremitci, Sercan
Seven, Gulseren
Keskin, Elmas Biberci
Koker, Ibrahim H.
Kochan, Koray
Senturk, Hakan
机构：
来源：
GASTROENTEROLOGY | 2023年 / 164卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1520
引用
收藏
页码：S1361 / S1361
页数：1
相关论文
共 50 条
  • [1] Results of Nucleos(t)ide Analog Treatment Discontinuation in Hepatitis B e-Antigen-Negative Chronic Hepatitis B: NUCSTOP Study
    Kiremitci, Sercan
    Kochan, Koray
    Seven, Gulseren
    Keskin, Elmas Biberci
    Okay, Gulay
    Akkoyunlu, Yasemin
    Koc, Meliha Meric
    Sumbul, Bilge
    Senturk, Hakan
    TURKISH JOURNAL OF GASTROENTEROLOGY, 2024, 35 (01): : 17 - +
  • [2] The 96-week clinical outcomes after cessation of nucleos(t)ide analog treatment in chronic hepatitis B patients
    Xu, Wen-Xiong
    Li, Yang-Mei
    Li, Jian-Guo
    Mei, Yong-Yu
    Chen, You-Ming
    Li, Xue-Jun
    Lin, Chao-Shuang
    Deng, Hong
    Zhao, Zhi-Xin
    Xie, Dong-Ying
    Gao, Zhi-Liang
    Peng, Liang
    GASTROENTEROLOGY REPORT, 2021, 9 (04): : 313 - 322
  • [3] Current Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Kim, Soon Sun
    Cheong, Jae Youn
    Cho, Sung Won
    GUT AND LIVER, 2011, 5 (03) : 278 - 287
  • [4] CHRONIC HEPATITIS B PATIENTS REFERRED FOR LIVER TRANSPLANTATION AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION
    Hirode, Grishma
    Pi, Steven
    Kim, Audrey
    Feld, Jordan J.
    Bhat, Mamatha
    Van Uum, Rafique
    Lilly, Les
    Selzner, Nazia
    Hansen, Bettina E.
    Janssen, Harry L. A.
    HEPATOLOGY, 2021, 74 : 913A - 914A
  • [5] Improving the Prediction of Relapse After Nucleos(t)ide Analogue Discontinuation in Patients With Chronic Hepatitis B
    Song, Do Seon
    Jang, Jeong Won
    Yoo, Sun Hong
    Kwon, Jung Hyun
    Nam, Soon Woo
    Bae, Si Hyun
    Choi, Jong Young
    Yoon, Seung Kew
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) : E892 - E903
  • [6] HIGH VIROLOGICAL RELAPSE RATE AFTER NUCLEOS(T)IDE ANALOGUE DISCONTINUATION IN CHRONIC HEPATITIS B
    Chi, H.
    Arends, P.
    Wong, D. K.
    Yim, C.
    Hansen, B. E.
    Janssen, H. L. A.
    JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S436 - S436
  • [7] Hepatitis B Virus-Specific T Cells as a Biomarker for Discontinuation of Nucleos(t)ide Analogue Therapy for Chronic Hepatitis B
    Tian, Yongjun
    Ou, Jing-hsiung James
    HEPATOLOGY, 2019, 69 (03) : 1342 - 1344
  • [8] The Baseline and On treatment Predictive Factors of Hepatitis B Relapse after Nucleos(t)ide Analogue Discontinuation in Chronic Hepatitis B: A Prospective study
    Kaewdech, Apichat
    Sripongpun, Pimsiri
    Jundee, Sawangpong
    Chamroonkul, Naichaya
    Piratvisuth, Teerha
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 236 - 236
  • [9] Adherence to nucleos(t)ide Analogue Therapy in Patients With Chronic Hepatitis B
    Manolakopoulos, Spilios
    Goulis, John
    Striki, Athanasia
    Deutsch, Melanie
    Perlepe, Nikoleta
    Triantos, Christos
    Papatheodoridis, George V.
    GASTROENTEROLOGY, 2015, 148 (04) : S1068 - S1068
  • [10] Increasing functional cure rate beyond 96 weeks after discontinuation of nucleos (t)ide analogue treatment in HBeAg-negative chronic hepatitis B: follow-up of the stop-NUC trial
    van Boemmel, Florian
    Stein, Kerstin
    Heyne, Renate
    Petersen, Jorg
    Buggisch, Peter
    Berg, Christoph
    Zeuzem, Stefan
    Stallmach, Andreas
    Sprinzl, Martin
    Schott, Eckart
    Pathil-Warth, Anita
    von Arnim, Ulrike
    Keitel, Verena
    Lohmeyer, Jurgen
    Georg, Simon Karl
    Trautwein, Christian
    Trein, Andreas
    Hueppe, Dietrich
    Cornberg, Markus
    Lammert, Frank
    Ingiliz, Patrick
    Zachoval, Reinhart
    Hinrichsen, Holger
    Zipprich, Alexander
    Klinker, Hartwig
    Wiesch, Julian Schulze Zur
    Schmiedeknecht, Anett
    JOURNAL OF HEPATOLOGY, 2023, 78 : S1147 - S1148
12345